Literature DB >> 32282174

Unmet medical needs and other challenges in the treatment of patients with schizophrenia.

Lisa W Goldstone1.   

Abstract

Schizophrenia is a chronic mental health disorder hallmarked by a variety of symptoms impacting mental state, emotions, and behaviors, including delusions, hallucinations, disorganized speech, grossly disorganized or catatonic behavior, negative symptoms, and cognitive impairment. Schizophrenia leaves patients with the inability to function appropriately in their daily lives, including at work, in relationships, and even with self-care. The exact cause of this disorder has yet to be elucidated; however, multiple factors, including genetic susceptibility and environmental influences, have been implicated in its development. Patients with schizophrenia frequently demonstrate medication nonadherence and have multiple concurrent comorbidities that lead to increased morbidity and mortality. Schizophrenia is estimated to affect more than 21 million individuals globally, and while many therapies have become available for management, the disorder still presents unique challenges to providers, caregivers, and the healthcare system. Unmet medical needs remain for this complex disease state, and research is ongoing to address these needs and improve the overall health and outcomes of patients living with schizophrenia.

Entities:  

Year:  2020        PMID: 32282174     DOI: 10.37765/ajmc.2020.43011

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  2 in total

1.  Patient Journey of Veterans with Schizophrenia: An Analysis of Treatment Patterns, Healthcare Resource Utilization and Costs.

Authors:  Charmi Patel; Ahong Huang; Li Wang; Yoshita Paliwal; Kruti Joshi
Journal:  Adv Ther       Date:  2022-01-07       Impact factor: 3.845

2.  Patient-psychiatrist discordance and drivers of prescribing long-acting injectable antipsychotics for schizophrenia management in the real-world: a point-in-time survey.

Authors:  Alexander Keenan; Dee Lin; Jason Shepherd; Hollie Bailey; Carmela Benson; Sophie Meakin
Journal:  BMC Psychiatry       Date:  2022-03-17       Impact factor: 3.630

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.